InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Powell Fred M, 首席财务官. Director active across 2 companies, notably Antares Pharma, INC.. In total, 6 disclosures have been recorded. History available since 8 June 2021. The latest transaction was disclosed on 24 May 2022 (Disposition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Fred M. Powell is the Executive Vice President and Chief Financial Officer of ANTARES PHARMA, INC. He is responsible for financial management and strategy for the company. Powell brings significant financial expertise, contributing to the company's growth and sustainability.